Clinical trials
Terminated Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
498 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 6 |
| 2002 | 5 |
| 2003 | 17 |
| 2004 | 17 |
| 2005 | 10 |
| 2006 | 33 |
| 2007 | 26 |
| 2008 | 29 |
| 2009 | 27 |
| 2010 | 24 |
| 2011 | 24 |
| 2012 | 21 |
| 2013 | 14 |
| 2014 | 18 |
| 2015 | 27 |
| 2016 | 17 |
| 2017 | 23 |
| 2018 | 22 |
| 2019 | 20 |
| 2020 | 19 |
| 2021 | 35 |
| 2022 | 19 |
| 2023 | 15 |
| 2024 | 13 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 498 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 21 |
| M.D. Anderson Cancer Center | 20 |
| Pfizer | 11 |
| Mayo Clinic | 10 |
| Vanderbilt-Ingram Cancer Center | 8 |
| European Organisation for Research and Treatment of Cancer - EORTC | 7 |
| Massachusetts General Hospital | 7 |
| SWOG Cancer Research Network | 7 |
| Alliance for Clinical Trials in Oncology | 6 |
| Stanford University | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 498 |
| Carcinoma, Non-Small-Cell Lung | 226 |
| Breast Neoplasms | 60 |
| Neoplasms | 52 |
| Neoplasm Metastasis | 51 |
| Small Cell Lung Carcinoma | 33 |
| Head and Neck Neoplasms | 28 |
| Adenocarcinoma of Lung | 27 |
| Prostatic Neoplasms | 27 |
| Colonic Neoplasms | 26 |
Trials
Showing 26 to 50 of 498. Each trial links to its page on Pharma Observatory.
398 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.